Colby S. Shemesh
- Oncology top 10%
- Molecular Biology
- Immunology top 10%
- Biomedical Engineering
- Pulmonary and Respiratory Medicine
- Co-authors
- Anand RotteSandhya GirishBenjamin WuJoy HsuPatrick TwomeyBen‐Quan ShenIraj HosseiniHailing Zhang
- Topics
- Cancer Immunotherapy and Biomarkers (11 papers)CAR-T cell therapy research (7 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Colby S. Shemesh
33 papers receiving 878 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 373
- Molecular Biology 343
- Immunology 268
- Biomedical Engineering 174
- Pulmonary and Respiratory Medicine 145
Countries citing papers authored by Colby S. Shemesh
This map shows the geographic impact of Colby S. Shemesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colby S. Shemesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colby S. Shemesh more than expected).
Fields of papers citing papers by Colby S. Shemesh
This network shows the impact of papers produced by Colby S. Shemesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colby S. Shemesh. The network helps show where Colby S. Shemesh may publish in the future.
Co-authorship network of co-authors of Colby S. Shemesh
This figure shows the co-authorship network connecting the top 25 collaborators of Colby S. Shemesh. A scholar is included among the top collaborators of Colby S. Shemesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colby S. Shemesh. Colby S. Shemesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, studybreakdown → | 26 |
| 2 | 12 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 37 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 6 | |
| 11 | 11 | |
| 12 | 13 | |
| 13 | 6 | |
| 14 | 188 | |
| 15 | 105 | |
| 16 | 36 | |
| 17 | 27 | |
| 18 | 46 | |
| 19 | 57 | |
| 20 | 51 |
About Colby S. Shemesh
Colby S. Shemesh is a scholar working on Oncology, Hepatology and Immunology, having authored 33 papers that have together received 899 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (373 citations), Immunology (268 citations) and Molecular Biology (343 citations). Colby S. Shemesh has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Anand Rotte, Sandhya Girish, Benjamin Wu, Joy Hsu, Patrick Twomey, Ben‐Quan Shen, Iraj Hosseini, Hailing Zhang, Hailing Zhang and Scott P. Henry. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.